Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Qualcomm is pivoting from phones to AI chips and software, aiming to blend edge intelligence with data-center power. ...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
When markets wobble, two names often stand out in semiconductors: Nvidia and AMD. This guide breaks down which is the...
AMD and Nvidia lead the AI GPU wave, but they aren’t identical bets. This guide breaks down how to compare them, with...
Two streaming giants are pulling in opposite directions in 2026. Netflix has stumbled, while Roku gains traction. Thi...
Oil prices jump and inflation data loom, setting the stage for a volatile week in crypto markets as traders weigh mac...
ATRenew (RERE) 2026 earnings in Q1 offer a clearer view of the company’s path forward. This guide breaks down what to...
A CEO’s dramatic pledge to fire anyone who won’t adopt AI highlights the tension between automation and the evolving ...
A surge in OpenClaw adoption, punctuated by thousands lining up outside Tencent, signals a new era for China's AI sec...
Greg Abel is stepping into big shoes as Warren Buffett's successor. This article breaks down three bold purchases he ...
As 2025 reshapes the housing market, first-time buyers gain access to more flexible programs and faster closings. Thi...